COMPRO Drug Patent Profile
✉ Email this page to a colleague
When do Compro patents expire, and when can generic versions of Compro launch?
Compro is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in COMPRO is prochlorperazine. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prochlorperazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Compro
A generic version of COMPRO was approved as prochlorperazine by COSETTE on November 24th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COMPRO?
- What are the global sales for COMPRO?
- What is Average Wholesale Price for COMPRO?
Summary for COMPRO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,150 |
| Drug Prices: | Drug price information for COMPRO |
| DailyMed Link: | COMPRO at DailyMed |
Recent Clinical Trials for COMPRO
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Stony Brook University | Phase 4 |
Pharmacology for COMPRO
| Drug Class | Phenothiazine |
US Patents and Regulatory Information for COMPRO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | COMPRO | prochlorperazine | SUPPOSITORY;RECTAL | 040246-001 | Jun 28, 2000 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
